Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study

Michael S. Khodadoust,Alain H. Rook,Pierluigi Porcu,Francine M. Foss,Alison J. Moskowitz,Andrei R. Shustov,Satish Shanbhag,Lubomir Sokol,Steven P. Fling,Nirasha Ramchurren,Robert H. Pierce,Asa Davis,Richard Shine,Shufeng Li,Sophia Fong,Jinah Kim,Yi Yang,Wendy M. Blumenschein,Jennifer H. Yearley,Biswajit Das,Rajesh Patidar,Vivekananda Datta,Erin Cantu,Justine N. McCutcheon,Chris Karlovich,P. Mickey Williams,Priyanka B. Subrahmanyam,Holden T. Maecker,Steven M. Horwitz,Elad Sharon,Holbrook E. Kohrt,Martin A. Cheever,Youn H. Kim

Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study

2019

Michael S. Khodadoust
Alain H. Rook
Pierluigi Porcu
Francine M. Foss
Alison J. Moskowitz
Andrei R. Shustov
Satish Shanbhag
Lubomir Sokol
Steven P. Fling
Nirasha Ramchurren
Robert H. Pierce
Asa Davis
Richard Shine
Shufeng Li
Sophia Fong
Jinah Kim
Yi Yang
Wendy M. Blumenschein
Jennifer H. Yearley
Biswajit Das
Rajesh Patidar
Vivekananda Datta
Erin Cantu
Justine N. McCutcheon
Chris Karlovich
P. Mickey Williams
Priyanka B. Subrahmanyam
Holden T. Maecker
Steven M. Horwitz
Elad Sharon
Holbrook E. Kohrt
Martin A. Cheever
Youn H. Kim

PURPOSETo assess the efficacy of pembrolizumabin patients with advanced relapsed or refractory mycosis fungoides(MF) or Sezary syndrome (SS).PATIENTS AND METHODSCITN-10 is a single-arm, multicent...

Keywords:

Dermatology
Phases of clinical research
Refractory Mycosis Fungoides
Pathology
Pembrolizumab
Medicine
in patient

Correction
Source
Cite
Save

References

Citations